Sirtuins Emerge as Key Alzheimer's Targets in 1,141-Study Global Review
A sweeping bibliometric analysis maps two decades of sirtuin-Alzheimer's research, spotlighting SIRT1/SIRT3 and NAD⁺ metabolism as top therapeutic frontiers.
Summary
Sirtuins are a family of proteins that depend on NAD⁺ to regulate gene activity and cellular health. Researchers analyzed 1,141 published studies from 62 countries to map how sirtuin research in Alzheimer's disease has evolved. They found the field accelerated sharply after 2015, with growing focus on how sirtuins influence oxidative stress, amyloid-beta buildup, autophagy, and epigenetic changes in the aging brain. SIRT1 and SIRT3 emerged as the most studied members, and NAD⁺ metabolism is now a top research priority. Despite strong preclinical evidence supporting sirtuins as drug targets, major gaps remain: few studies focus on individual sirtuin subtypes, most evidence comes from animal or cell models, and no robust clinical trials have confirmed benefits in humans with Alzheimer's.
Detailed Summary
Alzheimer's disease remains one of the most devastating and treatment-resistant conditions in aging medicine. Finding new molecular targets is urgent, and the sirtuin family of proteins has drawn intense interest over the past two decades. Sirtuins regulate a wide range of cellular processes — from DNA repair and inflammation to energy metabolism — all of which go awry in Alzheimer's. Understanding how broadly the field has developed, and where the critical gaps lie, is essential for guiding future investment.
Researchers from Shanxi Medical University conducted a comprehensive bibliometric analysis of sirtuin-Alzheimer's publications indexed in the Web of Science Core Collection. Using multiple analytical tools — CiteSpace, VOSviewer, bibliometrix, and Scimago Graphica — they mapped publication trends, co-authorship networks, citation patterns, and evolving research themes across 1,141 papers published by authors in 62 countries.
The field has grown steadily, with a notable acceleration after 2015. China led in publication volume (357 articles, 31%), while the United States dominated in total citations (22,190). Keyword and citation analysis revealed a clear thematic shift: early work described neurodegeneration broadly, while recent studies probe specific mechanisms. Current hotspots include oxidative stress regulation, SIRT1 and SIRT3 signaling, amyloid-beta pathways, mTOR and autophagy crosstalk, epigenetic modulation, and NAD⁺ metabolism. Multi-target therapeutic strategies are an emerging priority.
These findings suggest sirtuins — particularly SIRT1 and SIRT3 — are legitimate candidates for Alzheimer's drug development. NAD⁺ precursors like NMN and NR, which boost sirtuin activity, are already popular supplements and now have a growing mechanistic rationale in neurodegeneration. Clinicians and researchers should watch for isoform-selective sirtuin activators as a next wave of candidates.
However, the review exposes serious translational gaps. Most evidence is preclinical, isoform-specific studies are rare, and blood-brain barrier penetration of potential sirtuin-targeting compounds remains a major challenge. Clinical validation is essentially absent. This summary is based on the abstract only, as the full text was not available.
Key Findings
- SIRT1 and SIRT3 are the most studied sirtuin isoforms in Alzheimer's disease research globally.
- NAD⁺ metabolism emerged as a major post-2015 research hotspot, supporting interest in NMN and NR supplementation.
- Autophagy, oxidative stress, and amyloid-beta pathways are the dominant sirtuin-linked mechanisms in AD.
- China leads publication output; the US leads in citation impact, reflecting complementary global research roles.
- Robust clinical trials validating sirtuin-targeted therapies in Alzheimer's patients are still largely absent.
Methodology
This is a bibliometric and translational review analyzing 1,141 publications from the Web of Science Core Collection using CiteSpace, VOSviewer, bibliometrix R package, and Scimago Graphica. The study maps publication trends, co-authorship networks, citation bursts, and keyword clustering to identify research hotspots and gaps. Biological interpretation of bibliometric hotspots was layered onto the quantitative findings to generate mechanistic insights.
Study Limitations
This summary is based on the abstract only, as the full text was not available for review. The bibliometric methodology identifies research trends but cannot establish causality or confirm clinical efficacy of sirtuin-targeted interventions. The authors themselves note persistent gaps in isoform-specific studies, multi-molecular integration, and clinical validation.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: